Principia SGR logo

Principia SGR

Europe, Lombardia, Italy, Milan

Description

Principia SGR is a prominent Italian venture capital firm based in Milan, established in 2004. It operates as an independent asset management company specializing in closed-end investment funds dedicated to venture capital and private equity. The firm manages two primary funds, Principia II and Principia III (Digital), with combined commitments totaling approximately €90 million. This positions Principia SGR as a significant and long-standing player in the Italian innovation ecosystem, focusing on nurturing early and growth-stage companies.

Principia SGR primarily targets innovative companies across early-stage and growth-stage phases. Their investment thesis is strongly centered on the digital sector, as evidenced by both funds having a significant or exclusive focus on digital ventures. Principia II, launched in 2007 with €40 million in commitments, targets innovative SMEs with a digital emphasis. Principia III (Digital), established in 2013 with €50 million in commitments, is exclusively dedicated to digital companies. The firm seeks to invest in companies demonstrating strong growth potential and disruptive technologies within the digital landscape, reflecting a strategic commitment to the evolving tech market.

While specific initial cheque sizes are not explicitly published, based on their fund sizes and typical European early-to-growth stage VC practices, Principia SGR's first investments generally range from approximately €500,000 to €3,000,000. These figures translate to roughly $540,000 to $3,240,000 USD, with potential for larger follow-on investments as portfolio companies mature. Principia SGR is known for its active role in supporting its portfolio companies beyond capital, leveraging its network and expertise to foster growth. Their long-standing presence since 2004 underscores their commitment to nurturing the Italian tech and digital startup scene, contributing to the development of several successful ventures.

Investor Profile

Principia SGR has backed more than 47 startups, with 0 new investments in the last 12 months alone. The firm has led 20 rounds, about 43% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in Italy, France, United States.
  • Strong thematic focus on Health Care, Software, Biotechnology.
  • Typical check size: $500K – $3M.

Stage Focus

  • Series Unknown (49%)
  • Series A (23%)
  • Seed (11%)
  • Series C (4%)
  • Series B (4%)
  • Debt Financing (2%)
  • Series D (2%)
  • Series E (2%)
  • Convertible Note (2%)

Country Focus

  • Italy (74%)
  • France (9%)
  • United States (6%)
  • United Kingdom (6%)
  • Brazil (2%)
  • Canada (2%)

Industry Focus

  • Health Care
  • Software
  • Biotechnology
  • E-commerce
  • Medical Device
  • Life Science
  • Hardware
  • Biopharma
  • Advertising
  • Shopping
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Principia SGR frequently co-invest with?

A
Europe, Lombardia, Italy, Milano
Co-Investments: 3
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
dPixel
Europe, Lombardia, Italy, Milan
Co-Investments: 4
Atlante Ventures
Europe, Lombardia, Italy, Milano
Co-Investments: 3
Atlante Seeds
Europe, Lombardia, Italy, Milano
Co-Investments: 4
HF
Europe, Ile-de-France, France, Paris
Co-Investments: 3
F
Europe, Lombardia, Italy, Milan
Co-Investments: 3
Antares Capital
North America, Florida, United States, Miami
Co-Investments: 3
Nestlé Health Science
Europe, Vaud, Switzerland, Vevey
Co-Investments: 3

Which angels does Principia SGR often collaborate with?

PO
Europe, Rhone-Alpes, France, Lyon
Shared Deals: 1
LL
Europe, Lazio, Italy, Rome
Shared Deals: 1
FD
Europe, Lazio, Italy, Roma
Shared Deals: 1

What are some of recent deals done by Principia SGR?

KLISBio

Lomazzo, Lombardia, Italy

Silk-fibroin tissue engineering technology platform

BiotechnologyHealth CareLife ScienceMedical Device
Convertible NoteNov 26, 2021
Amount Raised: $3,396,001
WISE

Milan, Lombardia, Italy

WISE s.r.l is focused on the fabrication and commercial exploitation of electronic and MEMS devices on stretchable supports for apps.

HardwareSoftware
Series COct 1, 2020
Amount Raised: $17,616,075
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
COMPASS Pathways

Altrincham, Cheshire, United Kingdom

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
Series AOct 3, 2018
Amount Raised: $32,350,399
ComfTech s.r.l.

Monza, Lombardia, Italy

ComfTech design and produce sensing garments easy to dress and use for continuous non-intrusive monitoring of biomedical parameters.

BabyElectronicsHealth CareManufacturingMedicalMedical DeviceProduct Design
Series UnknownAug 6, 2018
Amount Raised: $8,091,298
Crest Optics

Rome, Lazio, Italy

Crest Optics, a bioscience startup, produces instruments that use optical and electrooptical technology for scientific and industrial apps.

AppsBiotechnologyOptical Communication
Series UnknownJul 8, 2018
Amount Raised: $7,200,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625

Clinical Trial Center S.P.A. offers clinic research and trial services.

Clinical TrialsHealth Care
Series UnknownAug 12, 2017
WISE

Milan, Lombardia, Italy

WISE s.r.l is focused on the fabrication and commercial exploitation of electronic and MEMS devices on stretchable supports for apps.

HardwareSoftware
Series BMay 25, 2017
Amount Raised: $7,286,563
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390